<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78982</article-id><article-id pub-id-type="doi">10.7554/eLife.78982</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-277029"><name><surname>Liauw</surname><given-names>Brandon Wey-Hung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277030"><name><surname>Foroutan</surname><given-names>Arash</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277031"><name><surname>Schamber</surname><given-names>Michael R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277032"><name><surname>Lu</surname><given-names>Weifeng</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-277027"><name><surname>Samareh Afsari</surname><given-names>Hamid</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5839-4765</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-222458"><name><surname>Vafabakhsh</surname><given-names>Reza</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8384-3203</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular Biosciences</institution>, <institution>Northwestern University</institution>, <addr-line><named-content content-type="city">Evanston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution>Boehringer Ingelheim Pharmaceuticals, Inc</institution>, <addr-line><named-content content-type="city">Ridgefield</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-114412"><name><surname>Goldschen-Ohm</surname><given-names>Marcel P</given-names></name><role>Reviewing editor</role><aff><institution>University of Texas at Austin</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>hamid.samareh_afsari@boehringer-ingelheim.com</email> (HS);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>reza.vafabakhsh@northwestern.edu</email> (RV);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>07</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78982</elocation-id><history><date date-type="received"><day>26</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>30</day><month>06</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Liauw et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Liauw et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78982-v1.pdf"/><abstract><p>Activation of G protein-coupled receptors (GPCRs) is an allosteric process. It involves conformational coupling between the orthosteric ligand binding site and the G protein binding site. Factors that bind at non-cognate ligand binding sites to alter the allosteric activation process are classified as allosteric modulators and represent a promising class of therapeutics with distinct modes of binding and action. For many receptors, how modulation of signaling is represented at the structural level is unclear. Here, we developed FRET sensors to quantify receptor modulation at each of the three structural domains of metabotropic glutamate receptor 2 (mGluR2). We identified the conformational fingerprint for several allosteric modulators in live cells. This approach enabled us to derive a receptor-centric representation of allosteric modulation and to correlate structural modulation to the standard signaling modulation metrics. Single-molecule FRET analysis revealed that a NAM increases the occupancy of one of the intermediate states while a PAM increases the occupancy of the active state. Moreover, we found that the effect of allosteric modulators on the receptor dynamics is complex and depend on the orthosteric ligand. Collectively, our findings provide a structural mechanism of allosteric modulation in mGluR2 and suggest possible strategies for design of future modulators.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>None</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>NIGMS</institution></institution-wrap></funding-source><award-id>R01GM140272</award-id><principal-award-recipient><name><surname>Vafabakhsh</surname><given-names>Reza</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>NIGMS</institution></institution-wrap></funding-source><award-id>T32GM-008061</award-id><principal-award-recipient><name><surname>Liauw</surname><given-names>Brandon Wey-Hung</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Hamid Samareh Afsari, is affiliated with Boehringer Ingelheim Pharma GmbH &amp; Co. The author has no financial interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Accompanying source data is provided for figures 1-4 and tables 1-3. The PDB accession codes for human mGluR2 structures used are 7MTS, 7MTR, 7E9G, 7EPE, and 7EPF.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Seven AB</collab><collab>Barros-Alvarez X</collab><collab>Skiniotis G</collab></person-group><year iso-8601-date="2021">2021</year><source>CryoEM Structure of mGlu2 - Gi Complex</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7MTS">https://www.rcsb.org/structure/7MTS</ext-link><comment>PBD, 7MTS</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Seven AB</collab><collab>Barros-Alvarez X</collab><collab>Skiniotis G</collab></person-group><year iso-8601-date="2021">2021</year><source>CryoEM Structure of Full-Length mGlu2 Bound to Ago-PAM ADX55164 and Glutamate</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7MTR">https://www.rcsb.org/structure/7MTR</ext-link><comment>PDB, 7MTR</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Lin S</collab><collab>Han S</collab><collab>Zhao Q</collab><collab>Wu B</collab></person-group><year iso-8601-date="2021">2021</year><source>Cryo-EM structure of Gi-bound metabotropic glutamate receptor mGlu2</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7E9G">https://www.rcsb.org/structure/7E9G</ext-link><comment>PDB, 7E9G</comment></element-citation><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Du J</collab><collab>Wang D</collab><collab>Lin S</collab><collab>Han S</collab><collab>Wu B</collab><collab>Zhao Q</collab></person-group><year iso-8601-date="2021">2021</year><source>Crystal structure of mGlu2 bound to NAM563</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7EPE">https://www.rcsb.org/structure/7EPE</ext-link><comment>PDB, 7EPE</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Du J</collab><collab>Wang D</collab><collab>Lin S</collab><collab>Han S</collab><collab>Wu B</collab><collab>Zhao Q</collab></person-group><year iso-8601-date="2021">2021</year><source>Crystal structure of mGlu2 bound to NAM597</source><ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/7EPF">https://www.rcsb.org/structure/7EPF</ext-link><comment>PDB, 7EPF</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-78982-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>